GPHL’s Hanfang donates BPCs to develop vaccines against virus_GPHL Headline_

GPHL’s Hanfang donates BPCs to develop vaccines against virus

2020-02-09 19:17:56 GPHL GPHL

“On the Chinese New Year’s Day, we received an emergency order of 10 kg of soybean oil for injection from a Wuhan drug company and Wuhan municipal government. They will use them for developing and producing vaccines against the novel coronavirus.”

640.webp (58).jpg

On January 27th, Xu Ying, head of Marketing Dept. of GPHL’s Guangzhou Hanfang Pharmaceutical Co., Ltd. (Hanfang), told the reporter that employees of Production, Quality Assurance and Warehouse Departments cancelled their vacation, and prepared the required bulk pharmaceutical chemicals (BPCs) on the next day.

Hanfang subsequently donated those BPCs for supporting vaccine development. “We have already sent the BPCs to Wuhan Vaccine Research Centre.”

Hanfang is a high-tech company focusing on development and production of BPCs, premium pharmaceutical lipid excipients, health care products and preparation, and food for special medical purpose.

640.webp (59)_副本.jpg

During this crucial period, Hanfang will make an all-out effort to overcome all difficulties, and contribute to the development of vaccines against the 2019-nCoV virus.

The relief supplies donated by GPHL, such as Qingkailing, Xia Sang Ju Granule and the BPCs, have now arrived in Wuhan, and will be used for supporting the prevention and control of the 2019-nCoV infection.

In 2003, GPHL and its subsidiary Hanfang made a full-fledged assault on the SARS epidemic.

Authors: Michelle, Monica

Editors: Simon, Olivia